Fibromyalgia, mood disorders, cognitive test results, cognitive symptoms and quality of life in systemic lupus erythematosus
- PMID: 35383358
- PMCID: PMC9788827
- DOI: 10.1093/rheumatology/keac207
Fibromyalgia, mood disorders, cognitive test results, cognitive symptoms and quality of life in systemic lupus erythematosus
Abstract
Objectives: Cognitive dysfunction, and comorbidities such as mood disorder and fibromyalgia, are common in SLE. This study aims to explore the associations between fibromyalgia, mood disorders, cognitive symptoms and cognitive dysfunction in SLE patients, and their impact on quality of life.
Methods: We tested cognition in SLE patients and healthy controls, and evaluated cognitive symptoms, mood disorder, fibromyalgia, fatigue and quality of life using patient-reported outcome measures. We examined associations of these comorbidities with both patient-reported cognitive symptoms and cognitive test performance.
Results: High fibromyalgia symptom score and history of depression or anxiety were associated with cognitive dysfunction. There were no significant associations between current depression, anxiety symptoms or fatigue score and objective cognitive dysfunction. In contrast, mood disorder symptoms, history of mood disorder, fibromyalgia symptoms and fatigue all had significant associations with patient-reported cognitive symptoms. There were no significant associations between patient-reported cognitive symptoms and objective cognitive dysfunction. Objective cognitive dysfunction, patient-reported cognitive symptoms, history of mood disorder and fibromyalgia symptoms all had significant associations with poorer quality of life; fibromyalgia had the biggest impact.
Conclusions: Cognitive symptoms are common in SLE, but there were no associations between cognitive symptoms and objective cognitive dysfunction. Depression, anxiety and fibromyalgia were more consistently associated with patient-reported cognitive symptoms than with objective cognitive dysfunction. These factors all have a significant impact on quality of life. Understanding the discrepancy between patient-reported cognitive symptoms and cognitive test performance is essential to advance care in this area of unmet need.
Keywords: SLE; cognitive dysfunction; depression; fibromyalgia; quality of life.
© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology.
Figures
References
-
- Brey R, Holliday S, Saklad A. et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002;58:1214–20. - PubMed
-
- Al Rayes H, Tani C, Kwan A. et al. What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis. Semin Arthritis Rheum 2018;48:240–55. - PubMed
-
- Appenzeller S, Cendes F, Costallat LT.. Cognitive impairment and employment status in systemic lupus erythematosus: a prospective longitudinal study. Arthritis Rheum 2009;61:680–7. - PubMed
-
- Arntsen K, Wildman P, Gross D. Lupus: Patient Voices. Joint report by Lupus Research Alliance, Lupus Foundation of America and Lupus and Allied Diseases Association for the CDER and FDA2018. http://www.lupuspfdd.org/LupusPFDDReportwCover.pdf.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
